𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Significance of p53 mutations in patients with chronic lymphocytic leukemia : A sequential study of 30 patients

✍ Scribed by Nandita Barnabas; Muhammad Shurafa; Daniel L. Van Dyke; Sandra R. Wolman; Damon Clark; Maria J. Worsham

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
137 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The clinical course of lung carcinoma in
The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia
✍ Kalpaj Parekh; Valerie Rusch; Mark Kris πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 1 views

## BACKGROUND. Although patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary malignancies, including lung carcinoma, there is virtually no information about their clinical outcomes. To evaluate this, the authors reviewed their 20-year institutional e

Secondary Abnormalities of Chromosome 6q
Secondary Abnormalities of Chromosome 6q in B-Cell Chronic Lymphocytic Leukemia: A Sequential Study of Karyotypic Instability in 51 Patients
✍ Finn, William G.; Kay, Neil E.; Kroft, Steven H.; Church, Stephanie; Peterson, L πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 1 views

Although karyotypic abnormalities are well documented in B-cell chronic lymphocytic leukemia (B-CLL), few sequential cytogenetic studies have been done. In this study, peripheral blood lymphocytes from fifty-one patients with B-CLL were sequentially karyotyped over a mean interval of 13.8 months (ra

p53 mutation as the second event in juve
p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1
✍ Drorit Luria; Smadar Avigad; Ian J. Cohen; Batia Stark; Raphael Weitz; Rina Zaiz πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 1 views

risk of developing various malignancies, most of which are myeloid disorders. The observed loss of NF1 allele in the myeloid malignancies of NF1 patients suggests